US FDA expands use of Regeneron's Libtayo as add-on treatment for skin cancer

reuters.com/business/healthcare-pharmaceuticals/us-fda-expands-use-regenerons-libtayo-add-on-treatment-skin-cancer-2025-10-08

This story appeared on reuters.com, 2025-10-08 20:32:48.246000.
The Entire Business World on a Single Page. Free to Use →